Avant Wins Contract for Oral Vaccine for Anthrax and Plague
By ANDREW
POLLACK (NYT) 417 words
Late Edition -
Final , Section C , Page 12 , Column 3
ABSTRACT
- Avant
Immunotherapeutics receives contract from DynPort Vaccine Co,
Defense's department's contractor for development of vaccines
against possible biowarfare agents, to develop oral vaccine for
military that would work against anthrax and plague; oral vaccine
will probably take 5 to 10 years to develop; contract is for $2.8
million initially and could grow to $8 million over two years (M) A
biotechnology company has received a contract to develop an oral
vaccine for the military that would work against anthrax and plague.
If it works, the combination vaccine could be a major advance from
current vaccines, which require multiple injections.
The contract, which is expected to be announced today, was
awarded to Avant Immunotherapeutics of Needham, Mass., by the
DynPort Vaccine Company, the Defense Department's primary contractor
for development of vaccines against possible biowarfare agents.
How multi-packs work: A multi-pack is an archive
package that saves you money by allowing you to pre-purchase a set
number of articles in bulk at a reduced price. You can then debit
from your multi-pack and quickly access articles from the archive at
your convenience over the lifetime of the multi-pack.
Once you purchase an article, you may view it
as often as you like over the next 90 days. Archive articles do not
include photos, charts or graphics